Special Issue "Affective Disorders Psychopharmacology"
Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 61456
Interests: schizophrenia; antipsychotics; depression; antidepressants; bipolar depression; NMDA receptors; machine learning; medical apps; phonotherapy; sexology
Special Issues, Collections and Topics in MDPI journals
Recent years have seen the emergence of new treatments for affective disorders. Pharmacological compounds with established mechanisms of action nowadays coexist with new treatment options that transcend the traditional neurotransmitter pathways commonly associated with these conditions. Available pharmacological options are effective in a large number of patients. There is, however, a large number of individuals with affective disorders who do not respond or fully remit to available treatments. This ‘Affective disorders pharmacology’ Special Issue welcomes articles addressing the limitations of current pharmacological approaches. Work that proposes new approaches to the treatments of affective disorders is also welcome, including new strategies to detect treatment responsiveness or refractoriness by utilising a range of technologies, including those that explore brain structure and function, putative peripheral markers of affective disorders and genetic make-up/genetic variations across the spectrum of affective disorders.
Prof. Dr. Marek Krzystanek
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Affective disorders
- Mood disorders
- Major depressive disorders
- Bipolar affective disorders